Versor Investments LP lowered its stake in Paycor HCM, Inc. (NASDAQ:PYCR – Get Rating) by 53.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 12,833 shares of the company’s stock after selling 14,786 shares during the quarter. Versor Investments LP’s holdings in Paycor HCM were worth $379,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Raymond James & Associates increased its position in shares of Paycor HCM by 284.3% in the third quarter. Raymond James & Associates now owns 138,811 shares of the company’s stock valued at $4,103,000 after acquiring an additional 102,692 shares during the last quarter. Conestoga Capital Advisors LLC increased its position in Paycor HCM by 8.2% during the third quarter. Conestoga Capital Advisors LLC now owns 4,369,652 shares of the company’s stock worth $129,167,000 after buying an additional 329,620 shares during the last quarter. Granite Investment Partners LLC increased its position in Paycor HCM by 32.7% during the third quarter. Granite Investment Partners LLC now owns 954,574 shares of the company’s stock worth $28,217,000 after buying an additional 235,441 shares during the last quarter. Oak Thistle LLC acquired a new position in Paycor HCM during the third quarter worth approximately $241,000. Finally, Archford Capital Strategies LLC increased its position in Paycor HCM by 161.5% during the third quarter. Archford Capital Strategies LLC now owns 53,884 shares of the company’s stock worth $1,593,000 after buying an additional 33,280 shares during the last quarter. Institutional investors and hedge funds own 32.26% of the company’s stock.
Wall Street Analyst Weigh In
Separately, The Goldman Sachs Group lowered their price target on Paycor HCM from $34.00 to $30.00 and set a “neutral” rating on the stock in a research report on Thursday, November 3rd. Four equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $34.58.
Insiders Place Their Bets
Paycor HCM Price Performance
NASDAQ PYCR opened at $22.72 on Friday. The business has a fifty day moving average price of $26.32 and a two-hundred day moving average price of $27.97. Paycor HCM, Inc. has a fifty-two week low of $20.14 and a fifty-two week high of $34.95. The stock has a market capitalization of $4.00 billion, a PE ratio of -40.57 and a beta of 0.43.
Paycor HCM (NASDAQ:PYCR – Get Rating) last released its earnings results on Wednesday, November 2nd. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. Paycor HCM had a negative return on equity of 0.78% and a negative net margin of 20.89%. The firm had revenue of $118.30 million during the quarter, compared to analysts’ expectations of $113.37 million.
About Paycor HCM
Paycor HCM, Inc, through its subsidiaries, provides software-as-a-service (SaaS) human capital management (HCM) solutions for small and medium-sized businesses (SMBs) primarily in the United States. It offers cloud-native platform to address the comprehensive people management needs of SMB leaders. The company's SaaS based people management products include Cor HCM, a complete suite of HCM tools spanning HR, onboarding, payroll, compensation management, employee surveys, expenses, and reporting and analytics; Workforce Management, a solution with flexible time entry, overtime calculations, and scheduling capabilities with real-time payroll synchronization; Benefits Administration, a decision support solution to help leaders to streamline and optimize company's benefits administration; and Talent Management, an integrated compensation and performance management solution.
- Get a free copy of the StockNews.com research report on Paycor HCM (PYCR)
- MarketBeat: Week in Review 01/02-01/06
- Why is the CrowdStrike Stock Price Struggling?
- Four Undervalued Healthcare Stocks for 2023
- WWE Stock: Vince McMahon Wants Back In The Show
- NVIDIA Is Bottoming But Don’t Buy It Just Yet
Receive News & Ratings for Paycor HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paycor HCM and related companies with MarketBeat.com's FREE daily email newsletter.